Author

Tracy E. Garrett

Observed names: Tracy E Garrett, Tracy Garrett

Observed institutions: Medical University of South Carolina, Bluebird Bio (France), Bluebird Bio (United States)

OpenAlex ID: A5050285439

Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells

2018 · Kevin M. Friedman, Tracy E. Garrett, et al. · Human Gene Therapy · 208

NOV-002, a Glutathione Disulfide Mimetic, as a Modulator of Cellular Redox Balance

2008 · Danyelle M. Townsend, Lin He, et al. · Cancer Research · 94

Sensitive and adaptable pharmacological control of CAR T cells through extracellular receptor dimerization

2019 · Wai-Hang Leung, Joel Gay, et al. · JCI Insight · 81

Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens

2023 · Michael R. Schlabach, Sharon Lin, et al. · Journal of Clinical Investigation · 43

Ex Vivo Interleukin-12-Priming During CD8+ T Cell Activation Dramatically Improves Adoptive T Cell Transfer Antitumor Efficacy in a Lymphodepleted Host

2012 · Mark P. Rubinstein, Colleen A. Cloud, et al. · Journal of the American College of Surgeons · 38

Manufacturing an Enhanced CAR T Cell Product By Inhibition of the PI3K/Akt Pathway During T Cell Expansion Results in Improved In Vivo Efficacy of Anti-BCMA CAR T Cells

2015 · Molly R. Perkins, Shannon Grande, et al. · Blood · 27

Protective effects of a glutathione disulfide mimetic (NOV-002) against cisplatin induced kidney toxicity

2009 · Sara Jenderny, He Lin, et al. · Biomedicine & Pharmacotherapy · 27

Ablation of the ATP-binding cassette transporter, Abca2 modifies response to estrogen-based therapies

2012 · Jody T. Mack, Carol B. Brown, et al. · Biomedicine & Pharmacotherapy · 14

A Novel and Highly Potent CAR T Cell Drug Product for Treatment of BCMA-Expressing Hematological Malignances

2015 · Alena A. Chekmasova, Holly M. Horton, et al. · Blood · 8

A BCMA-specific CAR T cell produced with clinically scalable lentiviral and T cell manufacturing processes has potent anti-multiple myeloma activity

2015 · Tracy E Garrett, Alena A Chekmasova, et al. · Journal for ImmunoTherapy of Cancer · 4

Abstract 2175: KSQ-001: A CRISPR/Cas9-engineered tumor infiltrating lymphocyte (eTILTM) therapy for solid tumors

2020 · Mike Schlabach, Nick Colletti, et al. · Cancer Research · 3

Abstract 2296: Inhibition of the PI3K/Akt pathway during CAR T cell production results in enhanced efficacy across multiple in vivo tumor models

2016 · Shannon Grande, Molly R. Perkins, et al. · Cancer Research · 1

747. Towards the Clinical Application of BCMA CAR T Cells: The Importance of Reduced Tonic Signaling and Methods to Enhance Memory T Cells

2016 · Kevin Friedman, Holly Horton, et al. · Molecular Therapy

Iconography : Ablation of the ATP-binding cassette transporter, Abca2 modifies response to estrogen-based therapies

2012 · Jody T. Mack, Carol B. Brown, et al.

Works count: 14

Citation count: 548

H-index: 8

I10-index: 8